Getz Pharma Secures WHO Prequalification for Astola Facility

Getz Pharma secures WHO prequalification for its Astola facility, marking another milestone for Pakistan’s pharmaceutical industry and strengthening its global export prospects

Pakistan’s pharmaceutical industry has achieved another international milestone as Getz Pharma secured World Health Organization (WHO) pre-qualification for its Astola manufacturing facility on November 2, 2026. The announcement was made by Executive Chairperson Khalid Mahmood during a gathering of healthcare professionals at the company’s facility.

Addressing hundreds of physicians, surgeons and other medical professionals, Mahmood highlighted the significance of the recognition for Pakistan’s pharmaceutical sector. He said the achievement would enhance international trust in medicines manufactured in Pakistan while opening doors to greater export opportunities.

The latest recognition marks the company’s second manufacturing facility to receive WHO pre-qualification. Its first production facility achieved the same status in 2017, demonstrating the company’s continued efforts to meet internationally recognized pharmaceutical manufacturing and quality standards.

Mahmood also emphasized that the development reflects Pakistan’s growing potential in the global pharmaceutical market. He maintained that locally produced medicines can satisfy demanding international quality requirements and establish a stronger presence in overseas markets.

The recognition is expected to further strengthen Getz Pharma’s international standing while highlighting the capabilities of Pakistan’s pharmaceutical manufacturing industry. It also represents an opportunity for the country’s pharmaceutical exporters to expand their reach in markets where internationally recognized quality certifications are essential.